FDA Drug Safety Communication: FDA investigating rare brain infection in patient taking Gilenya (fingolimod) US Food and Drug Administration, 29 Aug 2013 Accessed on 13 Sep 2013 from http://www.fda.gov/Drugs/DrugSafety/ucm366529.htm. CommentRecommendBookmarkWatch